These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 16971735

  • 1. The role of bisphosphonates in early breast cancer.
    Paterson AH.
    Oncologist; 2006; 11 Suppl 1():13-9. PubMed ID: 16971735
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 3. Toward new horizons: the future of bisphosphonate therapy.
    Lipton A.
    Oncologist; 2004 Jul; 9 Suppl 4():38-47. PubMed ID: 15459428
    [Abstract] [Full Text] [Related]

  • 4. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton A.
    Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
    [Abstract] [Full Text] [Related]

  • 5. Managing metastatic bone pain: the role of bisphosphonates.
    Gralow J, Tripathy D.
    J Pain Symptom Manage; 2007 Apr; 33(4):462-72. PubMed ID: 17397707
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ, Dranitsaris G, Ooi WS, Yogendran G, Sukovic T, Wong BY, Verma S, Pritchard KI, Trudeau M, Cole DE.
    J Clin Oncol; 2006 Oct 20; 24(30):4895-900. PubMed ID: 17001071
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonates for breast cancer.
    Pavlakis N, Schmidt R, Stockler M.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD003474. PubMed ID: 16034900
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec 20; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 9. Breast cancer: bisphosphonate therapy for metastatic bone disease.
    Body JJ.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6258s-6263s. PubMed ID: 17062710
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
    Doggrell SA.
    Expert Rev Anticancer Ther; 2009 Sep 15; 9(9):1211-8. PubMed ID: 19761424
    [Abstract] [Full Text] [Related]

  • 11. The role of bisphosphonates in breast cancer.
    Coleman RE.
    Breast; 2004 Dec 15; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [Abstract] [Full Text] [Related]

  • 12. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A.
    Cancer Treat Rev; 2008 Dec 15; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [Abstract] [Full Text] [Related]

  • 13. Should oral bisphosphonates be standard of care in women with early breast cancer?
    Clemons M, Verma S.
    Breast Cancer Res Treat; 2005 Apr 15; 90(3):315-8. PubMed ID: 15830146
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
    Cartenì G, Bordonaro R, Giotta F, Lorusso V, Scalone S, Vinaccia V, Rondena R, Amadori D.
    Oncologist; 2006 Apr 15; 11(7):841-8. PubMed ID: 16880243
    [Abstract] [Full Text] [Related]

  • 15. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep 15; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 16. Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.
    Broom R, Du H, Clemons M, Eton D, Dranitsaris G, Simmons C, Ooi W, Cella D.
    J Pain Symptom Manage; 2009 Aug 15; 38(2):244-57. PubMed ID: 19364633
    [Abstract] [Full Text] [Related]

  • 17. Pharmacotherapy of bone metastases in breast cancer patients.
    Petrut B, Simmons C, Broom R, Trinkaus M, Clemons M.
    Expert Opin Pharmacother; 2008 Apr 15; 9(6):937-45. PubMed ID: 18377337
    [Abstract] [Full Text] [Related]

  • 18. Oral bisphosphonates as adjuvant therapy for operable breast cancer.
    Powles T, McCroskey E, Paterson A.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6301s-6304s. PubMed ID: 17062718
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonates and breast cancer incidence and recurrence.
    Chlebowski RT, Col N.
    Breast Dis; 2011 Oct 15; 33(2):93-101. PubMed ID: 22142660
    [Abstract] [Full Text] [Related]

  • 20. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D, Plestina S, Belev B, Unusić J, Pavlinić-Diminić V.
    Lijec Vjesn; 1999 Oct 15; 121(9-10):296-301. PubMed ID: 19658372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.